Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s software revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check22 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, indicating a website software update.SummaryDifference0.0%

- Check36 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a minor version upgrade to the page's revision label.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.6.6 now appears in the page footer, signaling a recent site update. This change affects only the website's versioning metadata and does not alter the study history data.SummaryDifference0.0%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.